Literature DB >> 22744193

Obesity after pediatric liver transplantation: prevalence and risk factors.

Shikha S Sundaram1, Estella M Alonso, Phil Zeitler, Wanron Yin, Ravinder Anand.   

Abstract

OBJECTIVES: Pediatric obesity has become a significant public health concern. The historical focus in pediatric liver transplant (LT) has been undernutrition, with limited knowledge regarding obesity. Therefore, we sought to determine the prevalence of obesity in pediatric LT, compare it to National Health and Nutrition Examination Surveys (NHANES) data, and identify risk factors for obesity in pediatric LT.
METHODS: SPLIT, which collects pediatric LT data at 39 centers, was queried for subjects ages 2 to 18 years at follow-up, LT between 1995 and 2007, and with at least 1 body mass index measured 1 to 5 years after LT.
RESULTS: Of 1706 individuals included, 44% had biliary atresia (47% boys, 58% white, mean age at LT 4.6 years). Of these individuals, 19% were obese at 1 year and 18% at 3 years, higher than in the general pediatric population reported by 2003-2004 NHANES, whereas 11% obesity at 5 years after LT was similar to NHANES data. Using logistic regression, Hispanic ethnicity (odds ratio [OR] 1.8, 95% confidence interval [CI] 1.19-2.23), steroid use at follow-up (OR 1.48, 95% CI 1.23-1.77), overweight (OR 4.34, 95% CI 2.91-6.68), and obesity (OR 10.62, 95% CI 5.9-19.65) at LT independently predicted post-LT obesity.
CONCLUSIONS: These findings suggest a need to broaden standard care to include obesity assessment and intervention in routine pre- and posttransplant care.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744193      PMCID: PMC3646643          DOI: 10.1097/MPG.0b013e318266243c

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  18 in total

1.  Impact of obesity on children undergoing liver transplantation.

Authors:  André A S Dick; James D Perkins; Austin L Spitzer; Oliver B Lao; Patrick J Healey; Jorge D Reyes
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

2.  Hyperlipidemia and obesity after orthotopic liver transplantation.

Authors:  S J Munoz; R O Deems; M J Moritz; P Martin; B E Jarrell; W C Maddrey
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study.

Authors:  E Mor; D Facklam; J Hasse; P Sheiner; S Emre; M Schwartz; C Miller
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

Review 4.  Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity.

Authors:  A Reuben
Journal:  Liver Transpl       Date:  2001-11       Impact factor: 5.799

5.  Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

Authors:  V J Canzanello; L Schwartz; S J Taler; S C Textor; R H Wiesner; M K Porayko; R A Krom
Journal:  Liver Transpl Surg       Date:  1997-01

Review 6.  Type 2 diabetes in children and adolescents. American Diabetes Association.

Authors: 
Journal:  Pediatrics       Date:  2000-03       Impact factor: 7.124

7.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

8.  Increased incidence of non-insulin-dependent diabetes mellitus among adolescents.

Authors:  O Pinhas-Hamiel; L M Dolan; S R Daniels; D Standiford; P R Khoury; P Zeitler
Journal:  J Pediatr       Date:  1996-05       Impact factor: 4.406

9.  Weight change and obesity after liver transplantation: incidence and risk factors.

Authors:  J E Everhart; M Lombardero; J R Lake; R H Wiesner; R K Zetterman; J H Hoofnagle
Journal:  Liver Transpl Surg       Date:  1998-07

10.  Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity.

Authors:  M D Stegall; G Everson; G Schroter; B Bilir; F Karrer; I Kam
Journal:  Transplantation       Date:  1995-11-15       Impact factor: 4.939

View more
  3 in total

Review 1.  The SPLIT research agenda 2013.

Authors:  Estella M Alonso; Vicky L Ng; Ravinder Anand; Christopher D Anderson; Udeme D Ekong; Emily M Fredericks; Katryn N Furuya; Nitika A Gupta; Stacee M Lerret; Shikha Sundaram; Greg Tiao
Journal:  Pediatr Transplant       Date:  2013-05-30

2.  Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium.

Authors:  Vicky Lee Ng; Barbara H Haber; John C Magee; Alexander Miethke; Karen F Murray; Sonia Michail; Saul J Karpen; Nanda Kerkar; Jean P Molleston; Rene Romero; Philip Rosenthal; Kathleen B Schwarz; Benjamin L Shneider; Yumirle P Turmelle; Estella M Alonso; Averell H Sherker; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-07-09       Impact factor: 4.406

Review 3.  Expert consensus on management of metabolic disease in Chinese liver transplant recipients.

Authors:  Tian Shen; Li Zhuang; Xiao-Dong Sun; Xiao-Sheng Qi; Zhi-Hui Wang; Rui-Dong Li; Wen-Xiu Chang; Jia-Yin Yang; Yang Yang; Shu-Sen Zheng; Xiao Xu
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.